Alcon Inc (ALC)
79.57
+1.15
(+1.47%)
USD |
NYSE |
May 03, 16:00
79.57
0.00 (0.00%)
After-Hours: 20:00
Alcon Market Cap: 39.25B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 39.25B |
May 02, 2024 | 38.68B |
May 01, 2024 | 38.73B |
April 30, 2024 | 38.27B |
April 29, 2024 | 38.83B |
April 26, 2024 | 38.85B |
April 25, 2024 | 38.89B |
April 24, 2024 | 39.25B |
April 23, 2024 | 39.83B |
April 22, 2024 | 39.76B |
April 19, 2024 | 39.24B |
April 18, 2024 | 38.70B |
April 17, 2024 | 38.97B |
April 16, 2024 | 39.27B |
April 15, 2024 | 40.00B |
April 12, 2024 | 40.09B |
April 11, 2024 | 40.60B |
April 10, 2024 | 40.54B |
April 09, 2024 | 40.78B |
April 08, 2024 | 41.35B |
April 05, 2024 | 41.83B |
April 04, 2024 | 41.24B |
April 03, 2024 | 41.47B |
April 02, 2024 | 40.30B |
April 01, 2024 | 40.46B |
Date | Value |
---|---|
March 28, 2024 | 41.08B |
March 27, 2024 | 41.08B |
March 26, 2024 | 40.76B |
March 25, 2024 | 40.92B |
March 22, 2024 | 41.24B |
March 21, 2024 | 41.39B |
March 20, 2024 | 41.73B |
March 19, 2024 | 41.79B |
March 18, 2024 | 41.50B |
March 15, 2024 | 41.92B |
March 14, 2024 | 42.38B |
March 13, 2024 | 43.08B |
March 12, 2024 | 43.47B |
March 11, 2024 | 43.48B |
March 08, 2024 | 43.05B |
March 07, 2024 | 42.87B |
March 06, 2024 | 42.30B |
March 05, 2024 | 41.93B |
March 04, 2024 | 42.37B |
March 01, 2024 | 42.78B |
February 29, 2024 | 41.70B |
February 28, 2024 | 42.27B |
February 27, 2024 | 40.04B |
February 26, 2024 | 39.72B |
February 23, 2024 | 39.49B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
19.46B
Minimum
Mar 23 2020
43.48B
Maximum
Mar 11 2024
34.03B
Average
34.37B
Median
May 07 2021
Market Cap Benchmarks
AC Immune SA | 236.37M |
CRISPR Therapeutics AG | 4.744B |
Addex Therapeutics Ltd | 9.566M |
NLS Pharmaceutics Ltd | 5.978M |
Molecular Partners AG | 130.76M |
Market Cap Related Metrics
PE Ratio | 40.60 |
PS Ratio | 4.175 |
PEG Ratio | 0.2109 |
Price to Book Value | 1.903 |
Price | 79.57 |
Earnings Yield | 2.46% |
PEGY Ratio | 0.2105 |
Operating PE Ratio | 38.00 |
Normalized PE Ratio | 40.60 |